金水宝胶囊联合非奈利酮在2型糖尿病合并慢性肾病治疗中的应用价值分析


【摘要】 目的:探究金水宝胶囊联合非奈利酮在2型糖尿病合并慢性肾病治疗中的应用价值。方法:将2022年10月—2023年3月景德镇市第三人民医院收治的2型糖尿病合并慢性肾病患者80例按照抽签法分为对照组和观察组,各40例。对照组采用常规治疗,观察组在上述治疗方案上加用金水宝胶囊联合非奈利酮。比较两组临床疗效、血糖水平、肾功能及炎症因子水平。结果:观察组总有效率高于对照组(Plt;0.05);治疗后观察组的空腹血糖和糖化血红蛋白均高于对照组,但两组之间差异均无统计学意义(Pgt;0.05);治疗后观察组β2微球蛋白(β2-MG)、胱抑素C(Cys C)和血肌酐(Scr)水平均低于对照组(Plt;0.05);治疗后观察组白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)水平均低于对照组(Plt;0.05)。结论:金水宝胶囊联合非奈利酮在2型糖尿病合并慢性肾病治疗中的应用价值较高,可改善肾功能,同时还能降低炎症因子。
【关键词】 金水宝胶囊 非奈利酮 2型糖尿病 慢性肾病
Application Value Analysis of Jinshuibao Capsules Combined with Finerenone in the Treatment of Type 2 Diabetes Mellitus Complicated with Chronic Kidney Disease/LIU Xiaohong, LIAO Feiyong, CHENG Zhongkai, CAO Hongbin, HUANG Yuji. //Medical Innovation of China, 2025, 22(04): 0-047
[Abstract] Objective: To explore the application value of Jinshuibao Capsules combined with Finerenone in the treatment of type 2 diabetes mellitus complicated with chronic kidney disease. Method: A total of 80 patients with type 2 diabetes mellitus combined with chronic kidney disease admitted to the Third People's Hospital of Jingdezhen from October 2022 to March 2023 were divided into control group and observation group according to lottery method ......
您现在查看是摘要页,全文长 11937 字符。